Washington, D.C.— The floodwaters of Hurricane Katrina destroyed hospitals, washed out medical records and separated thousands of patients from doctors and from nursing homes. Biomedical research labs at Tulane and other New Orleans universities have been devastated by the loss of research animals and frozen tissues, as well as extensive data files.
WASHINGTON, D.C.- The floodwaters of Hurricane Katrina destroyed hospitals, washed out medical records and separated thousands of patients from doctors and from nursing homes. Biomedical research labs at Tulane and other New Orleans universities have been devastated by the loss of research animals and frozen tissues, as well as extensive data files.
On the policy front, Republican plans to cut $10 billion over five years from the Medicaid program were put on hold as states struggled to provide care for thousands of evacuees. Medicaid officials are trying to make it easier for people from the Gulf region to qualify for healthcare services in other states, including coverage of prescription drug refills, vaccinations and insulin products. Hurricane victims don't have to document income eligibility or show previous coverage to gain Medicaid services.
Some members of Congress also would like to delay current plans to shift drug coverage for poor elderly patients from Medicaid to the new Medicare drug program, which will take affect January 1. The process for changing coverage of these dual-eligible seniors is in the works, though, and likely to continue.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Blood or Marrow Transplant Recipients Face Higher Skin Cancer Risk, Study Shows
February 13th 2025Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal antibody, chronic graft-versus-host disease and posttransplant immunosuppression.
Read More